Related Experiment Video
Updated: Feb 19, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Identifying treatment response to antihypertensives in patients with obesity-related hypertension
Ilse M Schrover1, Jannick A N Dorresteijn1, Jodine E Smits1
1Department of Vascular Medicine, University Medical Center Utrecht, P.O. Box 85500, 3584 GA Utrecht, The Netherlands.
Background:
In patients with obesity-related hypertension (ORH), reaction to antihypertensive medication is likely influenced by patientcharacteristics.
Methods:
Effects of aliskiren, moxonidine and hydrochlorothiazide on 24-h blood pressure (BP) were compared to placebo. Linear mixed effect models were used to analyze the effect of patient characteristics on BP levels and treatment response.
Results:
Systolic BP response to aliskiren was higher in patients with a BMI > 30.7 kg/m2 compared to patients with a BMI ≤ 30.7 kg/m2 (-21 mmHg versus -4 mmHg). In patients with a hsCRP > 1.8 mg/L the systolic BP response to aliskiren was higher than in patients with a low hsCRP (-15 mmHg versus -7 mmHg). Hydrochlorothiazide (HCTZ) treatment effect on systolic BP was -13 mmHg when heart rate > 71 beats/min compared to -3 mmHg when heart rate was ≤ 71 beats/min.
Conclusion:
In patients with ORH, BP response to aliskiren is positively related to BMI and hsCRP. Systolic BP response to HCTZ is positively related to heart rate and negatively to renin levels.
Trial Registration:
NCT01138423. Registered June 4th, 2010.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Drug Dosing: Obese Patients
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

